Effects of Lymphocytes in Early Neurodegeneration of ALS
Author Information
Author(s): Tada Satoru, Okuno Tatsusada, Yasui Teruhito, Nakatsuji Yuji, Sugimoto Tomoyuki, Kikutani Hitoshi, Sakoda Saburo
Primary Institution: Osaka University
Hypothesis
What role do lymphocytes play in the early stages of amyotrophic lateral sclerosis (ALS)?
Conclusion
Lymphocytes have a deleterious effect in the early stages of ALS by inhibiting M2 microglial activation.
Supporting Evidence
- Clinical onset was significantly delayed in mice lacking lymphocytes.
- Increased M2 microglial activation was observed in lymphocyte-deficient mice.
- The study suggests lymphocytes may accelerate neurodegeneration in ALS.
Takeaway
In mice with ALS, removing certain immune cells called lymphocytes made the disease start later and allowed other protective cells to work better.
Methodology
Transgenic mice were used to compare the effects of lymphocyte presence on disease onset and microglial activation.
Potential Biases
Potential bias due to the specific genetic background of the mouse models used.
Limitations
The study primarily focuses on a specific mouse model, which may not fully represent human ALS.
Participant Demographics
Mice used were male transgenic mice with specific genetic modifications.
Statistical Information
P-Value
0.0033
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website